Mahmoud Bukar Maina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahmoud Bukar Maina has a total of 350 co-authors. Here are the top co-authors by number of shared publications:
Zaid Muhammad
Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK
13 shared publications- Louise C. Serpell
Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK
12 shared publications Larema Babazau
Biomedical Science Research and Training Centre Damaturu, 620242, Gujba Road Damaturu, Yobe State, Nigeria
7 shared publicationsLouise C. Serpell
6 shared publicationsBaba Waru Goni
Biomedical Science Research and Training Centre Damaturu, 620242, Gujba Road Damaturu, Yobe State, Nigeria
5 shared publications- Celeste M. Karch
Department of Psychiatry, Washington University in St. Louis, St. Louis, USA
5 shared publications
Latest Publications
- Open Access
- 11 October 2026
- Published by Springer Nature in Translational Psychiatry
MAPT mutations are associated with rDNA transcriptional hyperactivation and nucleolar stress in cellular models
Tau is traditionally known for its role in microtubule stabilisation, with its pathological aggregation central to tauopathies such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Recent evidence suggests that tau also plays important nuclear and nucleolar roles, yet the implications of tau pathology on nucleolar function remain poorly understood. Here, we show that tau localises to the nucleolus in both differentiated SH-SY5Y cells and human iPSC-neurons, and that disease-associated MAPT mutations are associated with increased nucleolar tau accumulation (P301S, S305N, and IVS 10 + 16). Using high-content imaging, we found that mutant tau expression was associated with structural expansion of the nucleus and nucleolus, together with upregulation of key markers from all three nucleolar sub-compartments, consistent with increased nucleolar activity. qPCR and nucleolar RNA-selective dye staining demonstrated increased rDNA transcription and rRNA processing, consistent with enhanced nucleolar biosynthetic output in mutant tau-expressing cells. This increase in nucleolar activity was accompanied by markers of nucleolar stress and apoptosis, including p53 stabilisation, caspase 3/7 activation, and TUNEL positivity. Notably, pharmacological inhibition of RNA polymerase I in the inducible SH-SY5Y model attenuated caspase 3/7 activity, supporting a functional contribution of elevated rDNA transcriptional activity to downstream apoptotic signalling. Together, these findings identify altered nucleolar homeostasis as a feature associated with mutant tau expression and support a potential contribution of nucleolar dysregulation to disease-associated cellular dysfunction in MAPT-linked FTD.
- 11 October 2026
- Published by Springer Nature in Translational Psychiatry
Open AccessMAPT mutations are associated with rDNA transcriptional hyperactivation and nucleolar stress in cellular models
Tau is traditionally known for its role in microtubule stabilisation, with its pathological aggregation central to tauopathies such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Recent evidence suggests that tau also plays important nuclear and nucleolar roles, yet the implications of tau pathology on nucleolar function remain poorly understood. Here, we show that tau localises to the nucleolus in both differentiated SH-SY5Y cells and human iPSC-neurons, and that disease-associated MAPT mutations are associated with increased nucleolar tau accumulation (P301S, S305N, and IVS 10 + 16). Using high-content imaging, we found that mutant tau expression was associated with structural expansion of the nucleus and nucleolus, together with upregulation of key markers from all three nucleolar sub-compartments, consistent with increased nucleolar activity. qPCR and nucleolar RNA-selective dye staining demonstrated increased rDNA transcription and rRNA processing, consistent with enhanced nucleolar biosynthetic output in mutant tau-expressing cells. This increase in nucleolar activity was accompanied by markers of nucleolar stress and apoptosis, including p53 stabilisation, caspase 3/7 activation, and TUNEL positivity. Notably, pharmacological inhibition of RNA polymerase I in the inducible SH-SY5Y model attenuated caspase 3/7 activity, supporting a functional contribution of elevated rDNA transcriptional activity to downstream apoptotic signalling. Together, these findings identify altered nucleolar homeostasis as a feature associated with mutant tau expression and support a potential contribution of nucleolar dysregulation to disease-associated cellular dysfunction in MAPT-linked FTD.
- Open Access
Study of Ancestry, Health, Environment, and Late-Life Neurodegeneration (SAHEL)
INTRODUCTION: Dementia research in sub-Saharan Africa remains limited despite rapid population aging and substantial ancestral, environmental, and vascular diversity. The Study of Ancestry, Health, Environment, and Late-Life Neurodegeneration (SAHEL) characterizes late-life cognitive decline and neurodegeneration in north-eastern Nigeria. METHODS: SAHEL comprises community and hospital cohorts of adults aged 55 years or older in Yobe and Borno States. Participants undergo cognitive, functional, environmental, cardiovascular, metabolic, neuropsychiatric, and neurological assessments. Blood is collected for clinical profiling and biobanking, and consenting hospital participants provide skin biopsies for induced pluripotent stem cell generation. Planned analyses will integrate gut microbiota profiling, retinal imaging, and brain magnetic resonance imaging to investigate biological pathways and markers associated with healthy aging and cognitive outcomes. RESULTS: From August 2025 through February 2026, 1,044 community participants were screened (mean age, 69.4 years; 56.4% female); 379 (36.3%) screened positive for cognitive concern and entered longitudinal follow-up. The hospital cohort enrolled 102 participants (mean age, 73.5 years; 57.8% male), including participants with Alzheimer’s disease, vascular dementia, mixed dementia, and mild cognitive impairment. Blood was collected from 809 community participants and all hospital participants. The cohort includes Kanuri, Fulani, Hausa, Babur/Bura, and Shuwa Arab participants. DISCUSSION: SAHEL has established a large, deeply characterized aging and dementia research platform in north-eastern Nigeria. Its linked clinical, environmental, biomarker, genomic, imaging, microbiome, and cellular resources will enable investigation of population-specific risk and resilience mechanisms and strengthen dementia research and precision medicine in African populations.
Open AccessStudy of Ancestry, Health, Environment, and Late-Life Neurodegeneration (SAHEL)
INTRODUCTION: Dementia research in sub-Saharan Africa remains limited despite rapid population aging and substantial ancestral, environmental, and vascular diversity. The Study of Ancestry, Health, Environment, and Late-Life Neurodegeneration (SAHEL) characterizes late-life cognitive decline and neurodegeneration in north-eastern Nigeria. METHODS: SAHEL comprises community and hospital cohorts of adults aged 55 years or older in Yobe and Borno States. Participants undergo cognitive, functional, environmental, cardiovascular, metabolic, neuropsychiatric, and neurological assessments. Blood is collected for clinical profiling and biobanking, and consenting hospital participants provide skin biopsies for induced pluripotent stem cell generation. Planned analyses will integrate gut microbiota profiling, retinal imaging, and brain magnetic resonance imaging to investigate biological pathways and markers associated with healthy aging and cognitive outcomes. RESULTS: From August 2025 through February 2026, 1,044 community participants were screened (mean age, 69.4 years; 56.4% female); 379 (36.3%) screened positive for cognitive concern and entered longitudinal follow-up. The hospital cohort enrolled 102 participants (mean age, 73.5 years; 57.8% male), including participants with Alzheimer’s disease, vascular dementia, mixed dementia, and mild cognitive impairment. Blood was collected from 809 community participants and all hospital participants. The cohort includes Kanuri, Fulani, Hausa, Babur/Bura, and Shuwa Arab participants. DISCUSSION: SAHEL has established a large, deeply characterized aging and dementia research platform in north-eastern Nigeria. Its linked clinical, environmental, biomarker, genomic, imaging, microbiome, and cellular resources will enable investigation of population-specific risk and resilience mechanisms and strengthen dementia research and precision medicine in African populations.
- Open Access
A proteomic analysis of the PHF-forming tau fragment (tau297-391) following uptake into differentiated human neuronal SHSY5Y cells
Tau self-assembly and intracellular deposition is associated with a group of neurodegenerative diseases called tauopathies, which include Alzheimer’s disease (AD) and Pick’s disease. Here, we measured the proteome response in human neuronal cells (differentiated SH-SY5Y) following addition of a spontaneously amyloidogenic region of tau known as dGAE (tau297-391) which forms AD-like paired helical filaments in vitro and proteomic analysis showed increased endogenous tau expression. Further interactome analysis uncovered increased association between tau and proteins associated with nuclear chromatin, the nucleolus, and the spliceosome as well as the thiol-peroxidase, PRDX6 alongside an increase in reactive oxygen species (ROS). This work highlights a method to identify proteome pathways that may play an important role in the development of tau pathology.
Open AccessA proteomic analysis of the PHF-forming tau fragment (tau297-391) following uptake into differentiated human neuronal SHSY5Y cells
Tau self-assembly and intracellular deposition is associated with a group of neurodegenerative diseases called tauopathies, which include Alzheimer’s disease (AD) and Pick’s disease. Here, we measured the proteome response in human neuronal cells (differentiated SH-SY5Y) following addition of a spontaneously amyloidogenic region of tau known as dGAE (tau297-391) which forms AD-like paired helical filaments in vitro and proteomic analysis showed increased endogenous tau expression. Further interactome analysis uncovered increased association between tau and proteins associated with nuclear chromatin, the nucleolus, and the spliceosome as well as the thiol-peroxidase, PRDX6 alongside an increase in reactive oxygen species (ROS). This work highlights a method to identify proteome pathways that may play an important role in the development of tau pathology.
- Open Access
- 5 October 2025
- Published by Springer Nature in Research Square
Mutant MAPT Induces rDNA Transcriptional Hyperactivation and Nucleolar Stress in Cellular Models
Tau is traditionally known for its role in microtubule stabilization, with its pathological aggregation central to tauopathies such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Recent evidence suggests that tau also plays important nuclear and nucleolar roles, yet the implications of tau pathology on nucleolar function remain poorly understood. Here, we show that tau localises to the nucleolus in both differentiated SH-SY5Y cells and iPSC-derived neurons, and accumulates upon expression of disease-associated MAPT mutations (P301S, S305N, and IVS 10 + 16). Using high-content imaging, we demonstrate that mutant tau expression leads to structural expansion of the nucleus and nucleolus, with upregulation of key markers from all three nucleolar sub-compartments, indicating increased in nucleolar activity. qPCR and nucleolar RNA-selective dye staining confirmed increased rDNA transcription and rRNA processing, suggesting that mutant tau drives elevated nucleolar biosynthetic output. This hyperactivation is accompanied by hallmarks of nucleolar stress and apoptosis, including p53 stabilisation, caspase 3/7 activation, and TUNEL positivity. These findings identify nucleolar dysfunction as a downstream consequence of mutant tau expression and highlight disruption of nucleolar homeostasis as a potential contributor to tau-mediated neurotoxicity in MAPT-linked FTD.
- 5 October 2025
- Published by Springer Nature in Research Square
Open AccessMutant MAPT Induces rDNA Transcriptional Hyperactivation and Nucleolar Stress in Cellular Models
Tau is traditionally known for its role in microtubule stabilization, with its pathological aggregation central to tauopathies such as Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Recent evidence suggests that tau also plays important nuclear and nucleolar roles, yet the implications of tau pathology on nucleolar function remain poorly understood. Here, we show that tau localises to the nucleolus in both differentiated SH-SY5Y cells and iPSC-derived neurons, and accumulates upon expression of disease-associated MAPT mutations (P301S, S305N, and IVS 10 + 16). Using high-content imaging, we demonstrate that mutant tau expression leads to structural expansion of the nucleus and nucleolus, with upregulation of key markers from all three nucleolar sub-compartments, indicating increased in nucleolar activity. qPCR and nucleolar RNA-selective dye staining confirmed increased rDNA transcription and rRNA processing, suggesting that mutant tau drives elevated nucleolar biosynthetic output. This hyperactivation is accompanied by hallmarks of nucleolar stress and apoptosis, including p53 stabilisation, caspase 3/7 activation, and TUNEL positivity. These findings identify nucleolar dysfunction as a downstream consequence of mutant tau expression and highlight disruption of nucleolar homeostasis as a potential contributor to tau-mediated neurotoxicity in MAPT-linked FTD.
- Open Access
- 16 June 2025
- Vol. 66 (2) , 564-574
High burden of chronic kidney disease of unknown cause among patients receiving renal replacement therapy in Northeast Nigeria: A cross-sectional survey of haemodialysis units.
Chronic kidney disease (CKD) is emerging as a significant public health concern in northeastern Nigeria, particularly in states such as Yobe and Borno. Despite its increasing impact, there is a lack of data characterizing this public health issue. This study aims to explore the prevalence, spatial distribution, and risk factors for CKD among patients receiving haemodialysis (HD) in the region. A cross-sectional survey of HD centres in Yobe, Borno, and Jigawa States of Nigeria was conducted. Questionnaire responses were obtained on demographic, social, and clinical data. Spatial analyses were conducted to determine the geographic distribution of the cases. We identified 376 patients receiving HD services across 4 centres. Of these, 207 (55.1%) were male and the mean age was 46.56 ± 16.4. Most patients reside in urban areas (67.6%). The main pre-dialysis occupations included civil service (100 [26.6%]), agriculture (65 [17.3%]), and trading (58 [15.4%]). 'Hypertension' (195 [51.9%]) was the most common self-reported primary renal disease, followed by unknown causes (70 [18.6%]) and Diabetic Kidney Disease (30 [8%]). Regional analysis demonstrated a particularly high burden of disease in Bade and Jakusko Local Government Areas. Spatial analysis suggests the existence of a CKD hotspot geographically associated with communities along the River Yobe, raising the possibility of an important environmental cause of disease. This study also highlights the lack of access to adequate diagnosis and geographical clustering of CKD burden in this region. These findings further reinforce the need for population-representative studies to characterize the burden of CKD alongside strategic healthcare interventions and collaboration among stakeholders aimed at improving access to care.xs
- 16 June 2025
- Vol. 66 (2) , 564-574
Open AccessHigh burden of chronic kidney disease of unknown cause among patients receiving renal replacement therapy in Northeast Nigeria: A cross-sectional survey of haemodialysis units.
Chronic kidney disease (CKD) is emerging as a significant public health concern in northeastern Nigeria, particularly in states such as Yobe and Borno. Despite its increasing impact, there is a lack of data characterizing this public health issue. This study aims to explore the prevalence, spatial distribution, and risk factors for CKD among patients receiving haemodialysis (HD) in the region. A cross-sectional survey of HD centres in Yobe, Borno, and Jigawa States of Nigeria was conducted. Questionnaire responses were obtained on demographic, social, and clinical data. Spatial analyses were conducted to determine the geographic distribution of the cases. We identified 376 patients receiving HD services across 4 centres. Of these, 207 (55.1%) were male and the mean age was 46.56 ± 16.4. Most patients reside in urban areas (67.6%). The main pre-dialysis occupations included civil service (100 [26.6%]), agriculture (65 [17.3%]), and trading (58 [15.4%]). 'Hypertension' (195 [51.9%]) was the most common self-reported primary renal disease, followed by unknown causes (70 [18.6%]) and Diabetic Kidney Disease (30 [8%]). Regional analysis demonstrated a particularly high burden of disease in Bade and Jakusko Local Government Areas. Spatial analysis suggests the existence of a CKD hotspot geographically associated with communities along the River Yobe, raising the possibility of an important environmental cause of disease. This study also highlights the lack of access to adequate diagnosis and geographical clustering of CKD burden in this region. These findings further reinforce the need for population-representative studies to characterize the burden of CKD alongside strategic healthcare interventions and collaboration among stakeholders aimed at improving access to care.xs
- Open Access
- 12 April 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4) , e70145
Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative
INTRODUCTION: Africa, home to 1.4 billion people and the highest genetic diversity globally, harbors unique genetic variants crucial for understanding complex diseases like neurodegenerative disorders. However, African populations remain underrepresented in induced pluripotent stem cell (iPSC) collections, limiting the exploration of population‐specific disease mechanisms and therapeutic discoveries.METHODS: To address this gap, we established an open‐access African Somatic and Stem Cell Bank.RESULTS: In this initial phase, we generated 10 rigorously characterized iPSC lines from fibroblasts representing five Nigerian ethnic groups and both sexes. These lines underwent extensive profiling for pluripotency, genetic stability, differentiation potential, and Alzheimer's disease and Parkinson's disease risk variants. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 technology was used to introduce frontotemporal dementia‐associated MAPT mutations (P301L and R406W).DISCUSSION: This collection offers a renewable, genetically diverse resource to investigate disease pathogenicity in African populations, facilitating breakthroughs in neurodegenerative research, drug discovery, and regenerative medicine.Highlights: We established an open‐access African Somatic and Stem Cell Bank. 10 induced pluripotent stem cell lines from five Nigerian ethnic groups were rigorously characterized. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 technology was used to introduce frontotemporal dementia‐causing MAPT mutations. The African Somatic and Stem Cell Bank is a renewable, genetically diverse resource for neurodegenerative research.
- 12 April 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (4) , e70145
Open AccessSomatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative
INTRODUCTION: Africa, home to 1.4 billion people and the highest genetic diversity globally, harbors unique genetic variants crucial for understanding complex diseases like neurodegenerative disorders. However, African populations remain underrepresented in induced pluripotent stem cell (iPSC) collections, limiting the exploration of population‐specific disease mechanisms and therapeutic discoveries.METHODS: To address this gap, we established an open‐access African Somatic and Stem Cell Bank.RESULTS: In this initial phase, we generated 10 rigorously characterized iPSC lines from fibroblasts representing five Nigerian ethnic groups and both sexes. These lines underwent extensive profiling for pluripotency, genetic stability, differentiation potential, and Alzheimer's disease and Parkinson's disease risk variants. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 technology was used to introduce frontotemporal dementia‐associated MAPT mutations (P301L and R406W).DISCUSSION: This collection offers a renewable, genetically diverse resource to investigate disease pathogenicity in African populations, facilitating breakthroughs in neurodegenerative research, drug discovery, and regenerative medicine.Highlights: We established an open‐access African Somatic and Stem Cell Bank. 10 induced pluripotent stem cell lines from five Nigerian ethnic groups were rigorously characterized. Clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 technology was used to introduce frontotemporal dementia‐causing MAPT mutations. The African Somatic and Stem Cell Bank is a renewable, genetically diverse resource for neurodegenerative research.
- Open Access
Epidemic meningococcal meningitis outbreak due to serogroup-c in Yobe state northeastern Nigeria: risk factors and effect of reactive ring vaccination with pentavalent conjugate meningococcal vaccine
Background There had been a lull in the outbreak of epidemic meningococcal meningitis in Yobe State NE Nigeria for over a decade following the introduction of conjugate monovalent meningococcal vaccine against serogroup-A meningitis. However, an outbreak of serogroup C meningococcal meningitis was recorded for the first time in the state in 2024. Objective to describe the epidemiology of epidemic meningococcal meningitis outbreak due to serogroup C in Yobe State northeastern Nigeria and assess the effectiveness of reactive focused ring vaccination with conjugate pentavalent meningococcal vaccine (Men5) used for the first time in the state and Nigeria in the control of the outbreak. Methodology: cross sectional descriptive epidemiologic study. Results 2,948 cases of epidemic meningococcal meningitis and 72 mortalities (CFR 2.4%) were recorded between March and June 2024 in 12 (70.4%) out of 17 local government areas of the state. The highest incidence and mortality was recorded in the age group 1-20 years [2,547 (86.4%)], 54 (CFR 2.1%)] respectively, and lowest in the age group > 40 years [43 (1.5%), 0 (CFR 0.0%)]. Reactive ring vaccination with Men5 was administered to 581, 025 persons aged 1-30 years. There was a significant declined in both the incidence and mortality due to meningococcal meningitis following focused reactive ring vaccination campaign. Few [223, (0.0038%)] mild adverse events following immunization (e.g. mild to moderate pain or swelling or itching at vaccination site, mild headache, fever etc.) were observed among the vaccinees. Conclusion The epidemic of meningococcal meningitis due to sero-group C had similar clinical and epidemiologic pattern with previous outbreaks due to serogroup A. The used of mass reactive ring vaccination with Men5 focused on affected communities was both effective and safe in controlling the outbreak as well as preventing mortality due to meningitis in Yobe State northeastern Nigeria.
Open AccessEpidemic meningococcal meningitis outbreak due to serogroup-c in Yobe state northeastern Nigeria: risk factors and effect of reactive ring vaccination with pentavalent conjugate meningococcal vaccine
Background There had been a lull in the outbreak of epidemic meningococcal meningitis in Yobe State NE Nigeria for over a decade following the introduction of conjugate monovalent meningococcal vaccine against serogroup-A meningitis. However, an outbreak of serogroup C meningococcal meningitis was recorded for the first time in the state in 2024. Objective to describe the epidemiology of epidemic meningococcal meningitis outbreak due to serogroup C in Yobe State northeastern Nigeria and assess the effectiveness of reactive focused ring vaccination with conjugate pentavalent meningococcal vaccine (Men5) used for the first time in the state and Nigeria in the control of the outbreak. Methodology: cross sectional descriptive epidemiologic study. Results 2,948 cases of epidemic meningococcal meningitis and 72 mortalities (CFR 2.4%) were recorded between March and June 2024 in 12 (70.4%) out of 17 local government areas of the state. The highest incidence and mortality was recorded in the age group 1-20 years [2,547 (86.4%)], 54 (CFR 2.1%)] respectively, and lowest in the age group > 40 years [43 (1.5%), 0 (CFR 0.0%)]. Reactive ring vaccination with Men5 was administered to 581, 025 persons aged 1-30 years. There was a significant declined in both the incidence and mortality due to meningococcal meningitis following focused reactive ring vaccination campaign. Few [223, (0.0038%)] mild adverse events following immunization (e.g. mild to moderate pain or swelling or itching at vaccination site, mild headache, fever etc.) were observed among the vaccinees. Conclusion The epidemic of meningococcal meningitis due to sero-group C had similar clinical and epidemiologic pattern with previous outbreaks due to serogroup A. The used of mass reactive ring vaccination with Men5 focused on affected communities was both effective and safe in controlling the outbreak as well as preventing mortality due to meningitis in Yobe State northeastern Nigeria.
- Open Access
- 20 March 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (3) , e14538
Dementia in a resource‐constrained sub‐Saharan African setting: A comprehensive retrospective analysis of prevalence, risk factors, and management at the only neuropsychiatric facility in Northeastern Nigeria
INTRODUCTION: Dementia prevalence is increasing in sub‐Saharan Africa, potentially due to population growth and aging. Resource‐constrained settings such as Northeastern Nigeria face challenges in dementia management.METHODS: We assessed dementia burden and management at the Federal Neuropsychiatric Hospital Maiduguri, the only neuropsychiatric facility in Northeastern Nigeria. This retrospective analysis included patient records from 1999 to 2023 for individuals 60 year of age and older with a dementia diagnosis.RESULTS: Of the 1216 cases reported, Alzheimer's disease (60.5%) was the most common subtype, followed by vascular dementia (24.5%). Hypertension (41.6%) was the most frequent comorbidity. Memory loss was present in all cases, whereas behavioral symptoms like agitation presented in some cases. Treatments included cognitive enhancers (donepezil), supplements (gingko biloba), and non‐drug therapies (psychoeducation).DISCUSSION: The increasing burden of dementia at this sole facility highlights the urgent need for targeted interventions and further research to understand the underlying factors contributing to dementia in this population.Highlights: Dementia trends and management in a neuropsychiatric facility serving over 26 million people in Northeastern Nigeria. Alzheimer's disease accounted for 60.5% of the dementia cases reported, with hypertension as the leading comorbidity. There is an urgent need for improved diagnostic tools and health care infrastructure to address dementia in resource‐constrained settings. The findings lay the foundation for developing a dementia cohort as part of the Northern Nigeria Dementia Research Group.
- 20 March 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (3) , e14538
Open AccessDementia in a resource‐constrained sub‐Saharan African setting: A comprehensive retrospective analysis of prevalence, risk factors, and management at the only neuropsychiatric facility in Northeastern Nigeria
INTRODUCTION: Dementia prevalence is increasing in sub‐Saharan Africa, potentially due to population growth and aging. Resource‐constrained settings such as Northeastern Nigeria face challenges in dementia management.METHODS: We assessed dementia burden and management at the Federal Neuropsychiatric Hospital Maiduguri, the only neuropsychiatric facility in Northeastern Nigeria. This retrospective analysis included patient records from 1999 to 2023 for individuals 60 year of age and older with a dementia diagnosis.RESULTS: Of the 1216 cases reported, Alzheimer's disease (60.5%) was the most common subtype, followed by vascular dementia (24.5%). Hypertension (41.6%) was the most frequent comorbidity. Memory loss was present in all cases, whereas behavioral symptoms like agitation presented in some cases. Treatments included cognitive enhancers (donepezil), supplements (gingko biloba), and non‐drug therapies (psychoeducation).DISCUSSION: The increasing burden of dementia at this sole facility highlights the urgent need for targeted interventions and further research to understand the underlying factors contributing to dementia in this population.Highlights: Dementia trends and management in a neuropsychiatric facility serving over 26 million people in Northeastern Nigeria. Alzheimer's disease accounted for 60.5% of the dementia cases reported, with hypertension as the leading comorbidity. There is an urgent need for improved diagnostic tools and health care infrastructure to address dementia in resource‐constrained settings. The findings lay the foundation for developing a dementia cohort as part of the Northern Nigeria Dementia Research Group.
- Open Access
Inhibiting disulphide bonding in truncated tau297-391 results in enhanced self-assembly of tau into seed-competent assemblies
Tau undergoes fibrillogenesis in a group of neurodegenerative diseases termed tauopathies. Each tauopathy is characterized by tau fibrils with disease-specific conformations, highlighting the complexity of tau self-assembly. This has led to debate surrounding the precise mechanisms that govern the self-assembly of tau in disease, especially the involvement of disulphide bonding (DSB) between cysteine residues. In this study, we use a truncated form of tau, dGAE, capable of forming filaments identical to those in disease. We reveal the impact of DSB in dGAE assembly and propagation by resolving the global mechanisms that dominate its assembly. We found evidence for surface-mediated secondary nucleation and fragmentation being active in dGAE assembly. The inhibition of DSB during dGAE assembly leads to an enhanced aggregation rate through a reduced lag phase, but with no effect on the global assembly mechanisms. We suggest this is due to the formation a dominant, seed-competent species in the absence of DSB that facilitates elongation and secondary nucleation resulting in enhanced assembly. In vitro seeding assays reveal the recruitment of endogenous tau in a cell model only when using dGAE species formed under conditions that inhibit DSB. Our results further support the use of the in vitro dGAE tau aggregation model for investigating the mechanism of tau assembly, the effect of varying conditions on tau assembly and how these conditions affect the resultant species. Further studies may utilise dGAE and its aggregates to investigate tau seeding, propagation and to highlight or test potential targets for therapies that reduce the spread of pathologic tau throughout the brain.
Open AccessInhibiting disulphide bonding in truncated tau297-391 results in enhanced self-assembly of tau into seed-competent assemblies
Tau undergoes fibrillogenesis in a group of neurodegenerative diseases termed tauopathies. Each tauopathy is characterized by tau fibrils with disease-specific conformations, highlighting the complexity of tau self-assembly. This has led to debate surrounding the precise mechanisms that govern the self-assembly of tau in disease, especially the involvement of disulphide bonding (DSB) between cysteine residues. In this study, we use a truncated form of tau, dGAE, capable of forming filaments identical to those in disease. We reveal the impact of DSB in dGAE assembly and propagation by resolving the global mechanisms that dominate its assembly. We found evidence for surface-mediated secondary nucleation and fragmentation being active in dGAE assembly. The inhibition of DSB during dGAE assembly leads to an enhanced aggregation rate through a reduced lag phase, but with no effect on the global assembly mechanisms. We suggest this is due to the formation a dominant, seed-competent species in the absence of DSB that facilitates elongation and secondary nucleation resulting in enhanced assembly. In vitro seeding assays reveal the recruitment of endogenous tau in a cell model only when using dGAE species formed under conditions that inhibit DSB. Our results further support the use of the in vitro dGAE tau aggregation model for investigating the mechanism of tau assembly, the effect of varying conditions on tau assembly and how these conditions affect the resultant species. Further studies may utilise dGAE and its aggregates to investigate tau seeding, propagation and to highlight or test potential targets for therapies that reduce the spread of pathologic tau throughout the brain.
- Open Access
Somatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC Initiative
INTRODUCTION: Africa, home to 1.4 billion people and the highest genetic diversity globally, harbors unique genetic variants crucial for understanding complex diseases like neurodegenerative disorders. However, African populations remain underrepresented in induced pluripotent stem cell (iPSC) collections, limiting the exploration of population-specific disease mechanisms and therapeutic discoveries. METHODS: To address this gap, we established an open-access African Somatic and Stem Cell Bank. RESULTS: In this initial phase, we generated 10 rigorously characterized iPSC lines from fibroblasts representing five Nigerian ethnic groups and both sexes. These lines underwent extensive profiling for pluripotency, genetic stability, differentiation potential, and Alzheimer’s disease and Parkinson’s disease risk variants. CRISPR/Cas9 technology was used to introduce frontotemporal dementia-associated MAPT mutations (P301L and R406W). DISCUSSION: This collection offers a renewable, genetically diverse resource to investigate disease pathogenicity in African populations, facilitating breakthroughs in neurodegenerative research, drug discovery, and regenerative medicine.
Open AccessSomatic and Stem Cell Bank to Study the Contribution of African Ancestry to Dementia: African iPSC Initiative
INTRODUCTION: Africa, home to 1.4 billion people and the highest genetic diversity globally, harbors unique genetic variants crucial for understanding complex diseases like neurodegenerative disorders. However, African populations remain underrepresented in induced pluripotent stem cell (iPSC) collections, limiting the exploration of population-specific disease mechanisms and therapeutic discoveries. METHODS: To address this gap, we established an open-access African Somatic and Stem Cell Bank. RESULTS: In this initial phase, we generated 10 rigorously characterized iPSC lines from fibroblasts representing five Nigerian ethnic groups and both sexes. These lines underwent extensive profiling for pluripotency, genetic stability, differentiation potential, and Alzheimer’s disease and Parkinson’s disease risk variants. CRISPR/Cas9 technology was used to introduce frontotemporal dementia-associated MAPT mutations (P301L and R406W). DISCUSSION: This collection offers a renewable, genetically diverse resource to investigate disease pathogenicity in African populations, facilitating breakthroughs in neurodegenerative research, drug discovery, and regenerative medicine.